Stocks and Finance

Illumina

Illumina 4/23/2012

02:33 : After dropping its hostile bid for Illumina, Roche (RHHBY.PK) is reportedl - After dropping its hostile bid for Illumina, Roche (RHHBY.PK) is reportedly looking for alternative investments and is said to be in talks with the research centers of three large universities about buying their gene sequencing ...
Source : seekingalpha-com

Illumina 4/22/2012

06:20 : Roche talks to Illumina rivals after drops bid: paper - Swiss drugmaker Roche is looking for alternatives after it dropped a $6.8 billion hostile offer for genetic specialist Illumina , a newspaper reported on Sunday.
Source : ibtimes-com

Illumina 4/18/2012

12:21 : DEALWATCH: Battle May Be Over, But War For Illumina Could Resume - Despite deciding not to extend beyond Friday a $6.5 billion offer for U.S. diagnostics firm Illumina Inc. (ILMN)--effectively withdrawing from its bid to buy the gene sequencing firm--Roche Holding A.G. (ROG.VX) may not permanently abandon ...
Source : foxbusiness-com
11:01 : Roche Walks Away From $6.8B Illumina Takeover Bid - Swiss drugmaker Roche Holding AG (ROG.VX) said Wednesday that it decided not to extend beyond Friday a $6.8 billion hostile offer for gene sequencing specialist Illumina Inc. (Nasdaq: ILMN) after forecasting that the incumbents ...
Source : ibtimes-com
09:54 : Roche ready to walk away from $6.8 billion Illumina bid - ZURICH/NEW YORK (Reuters) - Swiss drugmaker Roche said on Wednesday it would not extend a $6.8 billion hostile offer for genetic specialist Illumina as the U.S. group's shareholders blocked its move to appoint new directors.
Source : reuters-com
09:52 : Roche to end bid to buy diagnostics firm Illumina - (04-18) 07:14 PDT , (AP) -- Swiss drugmaker Roche says it will end its offer to acquire U.S. diagnostics firm Illumina Inc. for about $6.5 billion after forecasting that Illumina shareholders will reject its ...
Source : sfgate-com
09:25 : Roche not to extend tender offer for Illumina - BOSTON (MarketWatch) -- Swiss pharmaceutical giant Roche said early Wednesday that it has decided not to extend its cash tender offer of $51.00 a share for Illumina Inc. . The offer is currently set to expire at 6:00 p.m. ET ...
Source : marketwatch-com
04:40 : Today is a big day for Illumina (ILMN) in its battle to fend off Roche's ... - Today is a big day for Illumina (ILMN) in its battle to fend off Roche's (RHHBY.PK) $6.7B bid, with shareholders due to vote on new directors at the company's annual meeting. Roche has made six nominations, which would give ...
Source : seekingalpha-com

Illumina 4/12/2012

16:16 : Roche Steps Up Courtship of Illumina - Roche stepped up its courtship of U.S. gene-sequencing company Illumina, again signalling that the Swiss company might find extra value in the reluctant target if Illumina agrees to begin takeover talks.
Source : wsj-com
09:46 : Illumina Is No Apple But Could Be Juicy If Roche's Bid Fails - I am always searching for the next Apple, but the probability of a company turning into another Apple is woefully low. However, from an investment perspective, finding another Apple simply means finding another stock ...
Source : forbes-com
01:56 : Roche sales up 2%, defends offer for Illumina - MADRID (MarketWatch) -- Swiss drugmaker Roche Holding AG on Thursday confirmed its full-year outlook, as it reported a sales rise of 2% for the first quarter. In an update, Roche said group sales rose to 11 billion Swiss francs ...
Source : marketwatch-com

Illumina 4/11/2012

17:22 : Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) share - Swiss drugmaker Roche (RHHBY.PK), in a new letter to Illumina (ILMN) shareholders a week ahead of a shareholders meeting for the maker of genetic analysis equipment, appears to indicate a willingness to raise its $51/share ...
Source : seekingalpha-com

Illumina 4/8/2012

10:37 : Roche looks at raising bid for Illumina - The Swiss drugs company, says it might consider lifting its bid to acquire the US genetic sequencing company that has rebuffed its previous takeover offers
Source : ft-com

Illumina 4/6/2012

15:12 : DealBook: I.S.S. Sides With Illumina in Proxy Fight Against Roche - The biggest of the proxy advisory firms wrote in a report that Illumina shareholders should re-elect all of the company's proposed directors, instead of voting for director candidates proposed by Roche.
Source : nytimes-com
14:56 : Illumina says firms recommend against Roche offer - NEW YORK (AP) -- Illumina Inc., which makes instruments for genetic analysis, said Friday that two shareholder advisory firms are recommending that Illumina shareholders reject Roche Holding AG's offer to buy ...
Source : usnews-com
14:14 : Two Proxy Advisory Firms Side With Illumina - Two proxy advisory firms recommended Illumina shareholders vote against Roche's nominees to Illumina's board, calling its takeover offer inadequate.
Source : wsj-com
14:12 : Proxy firm says Roche bid for Illumina too low - BOSTON (MarketWatch) -- Illumina Inc. said Friday that proxy-advisory firm Institutional Shareholder Services, or ISS, has determined that Roche's latest bid for Illumina is inadequate. After reviewing Roche's proposal, ...
Source : marketwatch-com

Illumina 4/4/2012

02:57 : Roche (RHHBY.PK) presses on its pursuit of Illumina (ILMN), appealing ... - Roche (RHHBY.PK) presses on its pursuit of Illumina (ILMN), appealing directly to shareholders in a letter which says its $51/share bid "represents a significant premium to where Illumina would likely trade on ...
Source : seekingalpha-com
02:38 : Roche steps up overtures in Illumina bid battle - ZURICH (Reuters) - Roche Holding AG stepped up its charm offensive towards Illumina shareholders as it battles to take over the U.S. gene sequencing company, telling them its increased $6.7 billion...
Source : reuters-com

Illumina 4/3/2012

06:59 : Roche urges Illumina investors to push for bid talks - ZURICH (Reuters) - Swiss drugmaker Roche urged Illumina shareholders to put pressure on the U.S. gene sequencing firm to enter takeover talks after its management rejected an improved $6.7 billion...
Source : reuters-com

Illumina 4/2/2012

14:49 : Illumina board rejects sweetened Roche offer - (Reuters) - Illumina Inc said on Monday that its board unanimously rejected Roche Holding's increased offer to buy the genetic sequencing company for $51 per share, or about $6.7 billion, saying it...
Source : reuters-com
04:23 : Illumina sees adjusted net at or above estimates - TEL AVIV (MarketWatch) -- Illumina Inc., the San Diego developer of life-science tools and systems for genetic analysis, said on Monday that it estimates first-quarter adjusted earnings to come in at or above consensus estimates on revenue ...
Source : marketwatch-com
03:19 : Roche (RHHBY.PK) may drop its $6.7B bid for Illumina (ILMN), according ... - Roche (RHHBY.PK) may drop its $6.7B bid for Illumina (ILMN), according to a report in SonntagsZeitung. Sources say Roche may run out of patience soon and views Illumina as a "nice-to-have" but not ...
Source : seekingalpha-com

Illumina 3/29/2012

14:09 : Biotech Stocks: Illumina analysts expect higher Roche bid - lllumina analysts said Thursday that Roche’s latest offer for the genomics blue-chip is still too low and expect the Swiss pharmaceutical giant to eventually sweeten the bid.
Source : marketwatch-com
12:04 : Roche could add to sweetener to land Illumina - ZURICH/LONDON (Reuters) - Roche Holding raised its bid for U.S. gene sequencing company Illumina to $6.7 billion in an effort to force its reluctant board to negotiate a sale and left the door open...
Source : reuters-com
10:41 : Roche Raises Illumina Bid To $6.5B, Bets On Future of Gene Sequencing - The Swiss pharmaceutical company increased its unsolicited offer for gene-sequencing company Illumina Inc. to $51 a share, 15 percent above Roche's initial bid in January.
Source : ibtimes-com
09:21 : Roche ([[RHHBY]] -0.9%) could up its bid even further if Illumina ([[ILMN] - Roche (RHHBY -0.9%) could up its bid even further if Illumina (ILMN +2%) were to hold talks, according to sources familiar with the situation. The drug giant just raised its bid to $51 a share, but could go higher still if ...
Source : seekingalpha-com
06:43 : Roche raises bid for US diagnostics firm Illumina - GENEVA (AP) -- Swiss pharmaceutical company Roche Group raised its offer for Illumina Inc. to $51 cash per share Thursday, in a bid to speed up a takeover of the U.S. diagnostics company....
Source : usnews-com
03:47 : Roche lifts Illumina bid to $51-share from $44.50 - TEL AVIV (MarketWatch) -- Roche, the Basel health-care major, lifted its takeover proposal for Illumina Inc. to $51 a share from $44.50. In a Thursday statement, Illumina, the San Diego provider of tools and ...
Source : marketwatch-com
02:54 : Roche (RHHBY.PK) raises its hostile offer for Illumina (ILMN) by 15% to ... - Roche (RHHBY.PK) raises its hostile offer for Illumina (ILMN) by 15% to $51/share, or ~$6.7B, hoping to close a deal more quickly with shareholders that have thus far been unimpressed by the perceived lowball offer. Illumina ...
Source : seekingalpha-com
actualidad Illumina -


Biotechnology

Pharmaceuticals

Medical Supplies

Medical Equipment

Health Care Providers

Copyright © 2009 Finaperf.com - Exchange rate - Investir - Stock Exchange - Börse - Finanças - Bolsa - Tous droits réservés
Site édité par Yanga.net - Contacts